Evidence map›Paper›PMID 40772478›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Reply: Reconsidering white matter vulnerability and biomarker interpretation across Lewy body dementia subtypes.

Naomi Hannaway, Angeliki Zarkali, Rohan Bhome, Ivelina Dobreva, George Ec Thomas, Elena Veleva, Irene Gorostiaga Belio, Katie Tucker, Amanda Heslegrave, Henrik Zetterberg and 1 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Naomi HannawayDementia Research Centre, UCL Institute of Neurology, London, UK.ORCID https://orcid.org/0000-0001-8608-7757
Angeliki ZarkaliDementia Research Centre, UCL Institute of Neurology, London, UK.
Rohan BhomeDementia Research Centre, UCL Institute of Neurology, London, UK.
Ivelina DobrevaDementia Research Centre, UCL Institute of Neurology, London, UK.
George Ec ThomasDementia Research Centre, UCL Institute of Neurology, London, UK.
Elena VelevaUnited Kingdom Dementia Research Institute, University College London, London, UK.
Irene Gorostiaga BelioDementia Research Centre, UCL Institute of Neurology, London, UK.
Katie TuckerDementia Research Centre, UCL Institute of Neurology, London, UK.
Amanda HeslegraveUnited Kingdom Dementia Research Institute, University College London, London, UK.
Henrik ZetterbergDepartment of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.
Rimona S WeilDementia Research Centre, UCL Institute of Neurology, London, UK.

Funding

Alzheimer's Research UK Clinical Research Fellowship 2018B-001Rosetrees trustUCLH Biomedical Research CentreWellcome TrustWellcome Trust 225263Z/22/ZWolfson Foundation and Eisai
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40772478
PMCPMC12329564

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.